CTMX
Price
$0.84
Change
-$0.01 (-1.18%)
Updated
Jan 17 closing price
Capitalization
65.74M
39 days until earnings call
MLEC
Price
$0.84
Change
-$0.01 (-1.18%)
Updated
Jan 17 closing price
Capitalization
32.17M
53 days until earnings call
Ad is loading...

CTMX vs MLEC

Header iconCTMX vs MLEC Comparison
Open Charts CTMX vs MLECBanner chart's image
CytomX Therapeutics
Price$0.84
Change-$0.01 (-1.18%)
Volume$621.18K
Capitalization65.74M
Moolec Science SA
Price$0.84
Change-$0.01 (-1.18%)
Volume$5.79K
Capitalization32.17M
CTMX vs MLEC Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. MLEC commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and MLEC is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CTMX: $0.84 vs. MLEC: $0.84)
Brand notoriety: CTMX and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 45% vs. MLEC: 27%
Market capitalization -- CTMX: $65.74M vs. MLEC: $32.17M
CTMX [@Biotechnology] is valued at $65.74M. MLEC’s [@Biotechnology] market capitalization is $32.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, MLEC is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 1 TA indicator(s) are bullish while MLEC’s TA Score has 5 bullish TA indicator(s).

  • CTMX’s TA Score: 1 bullish, 5 bearish.
  • MLEC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MLEC is a better buy in the short-term than CTMX.

Price Growth

CTMX (@Biotechnology) experienced а -4.56% price change this week, while MLEC (@Biotechnology) price change was -5.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CTMX is expected to report earnings on May 08, 2025.

MLEC is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($65.7M) has a higher market cap than MLEC($32.2M). MLEC YTD gains are higher at: 4.875 vs. CTMX (-18.447).
CTMXMLECCTMX / MLEC
Capitalization65.7M32.2M204%
EBITDA8.55MN/A-
Gain YTD-18.4474.875-378%
P/E Ratio5.25N/A-
Revenue127MN/A-
Total Cash118MN/A-
Total Debt10.6MN/A-
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXMLEC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
35%
Momentum
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
45%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
32%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bullish Trend 11 days ago
23%
Advances
ODDS (%)
Bullish Trend 13 days ago
78%
Bullish Trend 16 days ago
51%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 26 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
37%
Aroon
ODDS (%)
Bearish Trend 11 days ago
86%
Bullish Trend 11 days ago
5%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ODICX45.690.32
+0.71%
Invesco Discovery C
KLCKX13.460.09
+0.67%
Federated Hermes Kaufmann Large Cap R
FSTEX30.780.13
+0.42%
Invesco Energy Inv
CCISX9.480.03
+0.32%
Calamos International Small Cap Gr C
DDDAX20.80-0.03
-0.14%
13D Activist A

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.84%
MLEC - CTMX
42%
Loosely correlated
-1.29%
TECH - CTMX
40%
Loosely correlated
-0.35%
PYXS - CTMX
39%
Loosely correlated
+2.04%
CRBU - CTMX
37%
Loosely correlated
-0.65%
BCAB - CTMX
37%
Loosely correlated
+1.46%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
-1.29%
SPRB - MLEC
51%
Loosely correlated
-4.75%
WINT - MLEC
49%
Loosely correlated
-3.44%
CTMX - MLEC
42%
Loosely correlated
-0.84%
AAVXF - MLEC
38%
Loosely correlated
N/A
BLPH - MLEC
34%
Loosely correlated
N/A
More